Developing a universal flu vaccine to provide better protection against influenza.
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-10877646
This study is looking at new flu vaccines that could provide better and longer-lasting protection against different types of the flu, and it's for anyone who wants to help improve how we prevent flu infections.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10877646 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing new types of flu vaccines that can offer long-lasting and broad protection against various strains of the influenza virus. The approach involves innovative designs and delivery methods to enhance the immune response in patients. By evaluating these candidate vaccines, the research aims to identify effective solutions that could change how we prevent influenza infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at higher risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal flu vaccine that significantly reduces the incidence of influenza and its complications.
How similar studies have performed: Other research efforts have shown promise in developing universal flu vaccines, indicating that this approach has potential for success.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOODY, TONY — DUKE UNIVERSITY
- Study coordinator: MOODY, TONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.